)

ProMIS Neurosciences (PMN) investor relations material
ProMIS Neurosciences H.C. Wainwright 27th Annual Global Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Company overview and technology
Focuses on protein misfolding as the basis for antibody therapies targeting neurodegenerative diseases.
Utilizes the EpiSelect platform to generate highly selective antibodies.
Lead program, PMN310, is in clinical development for Alzheimer's disease.
Pipeline includes candidates for ALS, Parkinson's, MSA, and a vaccine program.
Emphasizes differentiation in efficacy and safety, especially regarding ARIA side effects.
Clinical development and trial progress
Phase 1b study for PMN310 is enrolling ahead of schedule at 22 US sites, with over 100 patients treated.
The study is placebo-controlled, randomized, and spans 12 months, focusing on biomarkers, safety, and clinical endpoints.
FDA fast track designation and DSMB approval to escalate dosing have been achieved.
Interim analysis is expected in Q2 next year, with final top-line results in Q4.
No cases of ARIA have been observed to date, with a safety profile comparable to placebo.
Scientific rationale and differentiation
PMN310 selectively targets toxic amyloid beta oligomers, avoiding monomers and plaque.
Preclinical and clinical data show no binding to plaque and no evidence of brain hemorrhage in animal studies.
The antibody is designed to maximize efficacy by focusing on the most pathogenic species.
Other marketed drugs bind plaque and monomers, leading to modest efficacy and higher ARIA risk.
The platform's computational approach enables precise epitope targeting.
Next ProMIS Neurosciences earnings date

Next ProMIS Neurosciences earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage